Drug Targets Liver to Stop Hepatitis C
Find out about a new DNA drug that may be able to stop Hepatitis C from replicating in the human liver on RxList.
Read the rest of this entry »Find out about a new DNA drug that may be able to stop Hepatitis C from replicating in the human liver on RxList.
Read the rest of this entry »Kalbitor is effective in treating potentially life-threatening attacks of hereditary angioedema.
Read the rest of this entry »HIV/AIDS research lends itself to greater continued clinical results including HIV antiretrovirals, treatment advances and better medications.
Read the rest of this entry »Marla C. Dubinsky, M.D., director of the Cedars-Sinai Pediatric Inflammatory Bowel Disease Center and one of the world’s leading researchers studying the disease, has been named the Abe and Claire Levine Chair in Pediatric Inflammatory Bowel Disease. The endowed chair, presented in November, will fund continuing research to find groundbreaking new treatments for IBD…
Read the rest of this entry »Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn. ZEGERID OTC will be marketed over-the-counter by Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc…
Read the rest of this entry »A new study adds to evidence that bacterial vaginosis, the most common vaginal infection in women of childbearing age, is a sexually transmitted disease.
Bacterial vaginosis, or BV, occurs when the normal balance of “good” and “bad” bacteria in the vagina is upset. While certain sexual risk factors, like having multiple partners, have been linked to [...]